GDF15 and nonpapillary renal cell carcinoma: High circulating GDF-15 levels showed a significant correlation with a faster decline of renal function in patients with diabetes mellitus type 1, IgA nephropathy, and CKD stages 1–4 [44,45,46], suggesting its possible relevance as a marker of progression in ccRCC.